Goldman Sachs weighs in on the pharmacy wars, noting CVS Caremark (CVS +2.2%) still has room to...

|About: CVS Health Corporation (CVS)|By:, SA News Editor

Goldman Sachs weighs in on the pharmacy wars, noting CVS Caremark (CVS +2.2%) still has room to grow based on its "distinctive positioning" in the sector. Despite all the sound and fury from Walgreen (WAG -0.1%) on recapturing its lost customers back, the opposite appears to be the reality as the CVS share in the prescription market rises instead of falls.